Use access key #2 to skip to page content.

inthemoneystock (< 20)

Gilead Sciences Sets Up As A Beautiful Short



February 27, 2014 – Comments (2) | RELATED TICKERS: GILD

The biotech sector is in one of the biggest bubbles since the era. Some of the largest biotechnology companies in the world have doubled and tripled their size in the last year. One such stock is Gilead Sciences, Inc. (NASDAQ:GILD). The stock is hovering up 100% from its lows a year ago and has a market cap of $128 billion.

Reasons For The Short:

1. Biotech sector in a bubble with cracks emerging.

2. Gildead Sciences is up 100% in the last year with no significant pull backs.

3. The valuation is unsustainable for Gilead Sciences in the near term.

4. The stock has not been able to push through the technically important $85.00 level.

Overall, this sector has been an area where money has continued to flow. The music appears like it is coming to a stop. Gilead should have a pull back to $76.00 then $65,00.


Gareth Soloway

2 Comments – Post Your Own

#1) On February 27, 2014 at 1:58 PM, jiltin (46.08) wrote:

This analysis looks wrong. What is the justification of saying "Biotech sector in a bubble with cracks emerging".

It has consistantly paying me good returns... 

Report this comment
#2) On February 27, 2014 at 2:07 PM, BUbulldog (32.63) wrote:

Short away amigo! All of us that put a real analysis into the stock will much appreciate the added boost from the resulting short squeeze in a few months.

Report this comment

Featured Broker Partners